Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 700-518-3 | CAS number: 38233-76-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Additional information
A bacterial reverse mutation test was conducted (Kashima Laboratory, Mitsubishi-Kasei Institute of Toxicological and Environmental Sciences, 1989) according to official Japanese test guidelines, and in compliance with GLP. Strains of Salmonella Typhimurium (TA98, TA100, TA1535, and TA1537) and E. Coli (WP2 uvrA) were treated with increasing concentrations of ETD by the preincubation method, with and without metabolic activation (S9 Mix). The S. Typhimurium strains were tested up to the point of cytoxicity, and the E. Coli strain up to the point of precipitation. Treatment with the test material did not induce any increase in the number of revertant colonies relative to the concurrent solvent controls, and no the test material was concluded not to have shown any mutagenic potential in this test.
A chromosomal aberration study was conducted (Kashima Laboratory, Mitsubishi-Kasei Institute of Toxicological and Environmental Sciences, 1989) according to official Japanese test guidelines, and in compliance with GLP. Chinese hamster lung fibroblast cells were treated with ETD with and without metabolic activation (S9 Mix), and then the subsequent incidence of chromosomal aberrations was determined and compared against concurrent solvent control samples. The incidence of cells with aberrant chromosomes did not increase significantly in any of the treatment groups relative to the controls, and therefore the test was concluded to have been negative; ETD did not display mutagenic potential in this test.
An In-vivo Mammalian Cell Gene mutation study was conducted (RCC Cytotest Cell Research GMBH, 1999) according to OECD test guideline 476 and EEC directive 87/302, and in compliance with GLP. Mouse Lymphoma L5178Y cells were treated with ETD a increasing concentrations, with and without metabolic activation. Under the experimental conditions, the test item induced mutations in the mouse lymphoma thimidine kinase locus assay using the cell line L5178Y at highly toxic concentrations following continuous treatment for 24 hours.
Short description of key information:
Bacterial reverse mutation (S Typhimurium TA98, TA100, TA1535, and TA1537, and E Coli WP2 uvrA); no mutagenic activity, with and without metabolic activation.
Chromosome aberration, Chinese Hamster Lung Fibroblasts: No mutagenic potential, with or without metabolic activation.
Mammalian cell gene mutation: Mouse lymphoma L5178Y cells assay: Mutations seen at highly toxic concentrations.
Endpoint Conclusion: Adverse effect observed (positive)
Justification for classification or non-classification
No mutagenic activity was observed in either a bacterial reverse muation (Ames) test or the chromosomal aberration test conducted in mammalian cells in vitro, however an in-vitro gene mutation study in mammalian cells (Mouse lymphoma L5178Y cells) did present mutagenic activity when tested at cytotoxic concentrations. Whilst it may be reasonable to propose that the mutagenic activity seen in the gene mutation test is a result of the cytotoxic activity, the mutagenic potential of ETD cannot be discounted without additional, higher-tier testing (typically in-vivo testing), and so ETD must be considered mutagenic.
According to EC Regulation 1272/2008, ETD is classified as Mutagenic, category 2; the associated Hazard phrase is "H341: Suspected of causing genetic defects". The corresponding classification under the Dangerous Substances Directive (67/548/EEC) is: Mutagen category 3, "R68, Possible risk of irreversible effects".
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.